Pfizer France
在场
Pfizer France 的所有者是 Pfizer.
是其中之一......
Pfizer 是一家在股票代码 PFE (US) 下上市的公司。
Pfizer 在 41 个国家有直接业务。Pfizer 拥有 49家子公司，其中包括 Global Blood Therapeutics、Pfizer APAC 和 Pfizer Australia。
他们在：
涉及Pfizer的并购和融资。
- Pfizer 已收购 Global Blood Therapeutics (公布2022十月6号).
- Pfizer has announced the acquisition of Global Blood Therapeutics (公布2022八月9号).
- Pfizer 已收购 ReViral (公布2022七月20号).
- Pfizer has announced the acquisition of Biohaven Pharmaceutical (公布2022五月12号).
- Pfizer has announced the acquisition of ReViral (公布2022四月8号).
- Pfizer has announced the acquisition of Arena Pharmaceuticals (公布2021十二月13号).
- Pfizer 已收购 Trillium Therapeutics (公布2021十一月17号).
- Pfizer 已收购 Trillium Therapeutics (公布2021十月27号).
- Pfizer has announced the acquisition of Trillium Therapeutics (公布2021八月25号).
- Pfizer has announced the acquisition of Amplyx Pharmaceuticals (公布2021四月29号).
高管
查看带有其 14 名主要高管的组织结构图
Pfizer France 搜索最多的简介
- Henriette Rosenquist, President
- Jerome Lyon-Caen, Finance Director
- Jérôme Mouminoux, Director Market Access, Public Affairs, Commun...
高管在Pfizer变化
- Drew Panayiotou已作为Global Chief Marketing Officer加入公司 (新闻发布的2022九月5号).
创建提醒
跟踪 Pfizer France 的高管变动
药店
Pfizer 拥有 1,971 家竞争者，其中包括 Johnson & Johnson (美国(美洲))、Roche (瑞士) 和 Sanofi (法国)。
Popular M&A news in 药店
- Cencora的新名称是Cencora。 (公布2023一月24号).
- Sun Pharma has announced the acquisition of Concert Pharmaceuticals (公布2023一月24号).
- SetPoint Medical 刚刚宣布为 80 筹款数百万美元。 (公布2023一月24号).
药店 行业的其他推荐联系人
消息
Pfizer France 的最新新闻稿
- Communiqués de presse | Laboratoire de Recherches, Laboratoire Pharmaceutique
- Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company |
- Pfizer Inc. Recommends Rejection of Unsolicited Note Tender Offer by Huguenot Bond Liquidity, LLC | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company
- Pfizer Inc. Recommends Rejection of Unsolicited Note Tender Offer by Huguenot Bond Liquidity, LLC | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company
- Pfizer Prices $4,000,000,000 Debt Offering | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company
- Pfizer Prices $4,000,000,000 Debt Offering | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company
- Pfizer’s New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) Support Advancement into Pivotal Phase 3 Study | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical comp
- Pfizer’s New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) Support Advancement into Pivotal Phase 3 Study | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical comp
- Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest
- Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest
- View more press releases Close
通过电子邮件
